(Q36350050)

English

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2. (English)

1 reference

Europe PubMed Central

13 August 2017

author name string

Rosenberg SA

1

1 reference

Europe PubMed Central

13 August 2017

Mulé JJ

2

1 reference

Europe PubMed Central

13 August 2017

Spiess PJ

3

1 reference

Europe PubMed Central

13 August 2017

Reichert CM

4

1 reference

Europe PubMed Central

13 August 2017

Schwarz SL

5

1 reference

Europe PubMed Central

13 August 2017

language of work or name

0 references

publication date

1 May 1985

1 reference

Europe PubMed Central

13 August 2017

Journal of Experimental Medicine

1 reference

Europe PubMed Central

13 August 2017

161

1 reference

Europe PubMed Central

13 August 2017

5

1 reference

Europe PubMed Central

13 August 2017

1169-1188

1 reference

Europe PubMed Central

13 August 2017

Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187617

30 September 2017

T cell growth factor receptors. Quantitation, specificity, and biological relevance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187617

30 September 2017

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187617

30 September 2017

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187617

30 September 2017

Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187617

30 September 2017

In vitro growth of murine T cells. I. Production of factors necessary for T cell growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187617

30 September 2017

Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187617

30 September 2017

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187617

30 September 2017

Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187617

29 June 2018

Accurate identification of experimental pulmonary metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187617

29 June 2018

Fetal calf serum-induced blastogenic and cytotoxic responses of human lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187617

29 June 2018

In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187617

22 September 2018

Recovery of the in vivo cytotoxic T-cell response in cyclophosphamide-treated mice by injection of mixed-lymphocyte-culture supernatants

1 reference

https://pubmed.ncbi.nlm.nih.gov/3886826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Purified human interleukin-2 enhances induction of immune interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/3886826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo administration of Interleukin-2 enhances specific alloimmune responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/3886826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with lectins

1 reference

https://pubmed.ncbi.nlm.nih.gov/3886826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production

1 reference

https://pubmed.ncbi.nlm.nih.gov/3886826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological Activity of Recombinant Human Interleukin-2 Produced inEscherichia coli

1 reference

https://pubmed.ncbi.nlm.nih.gov/3886826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cell factor (interleukin 2) allows in vivo induction of T helper cells against heterologous erythrocytes in athymic (nu/nu) mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/3886826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/3886826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic administration of recombinant human interleukin-2 in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/3886826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of fresh human solid tumor cells by autologous lymphocytes activated in vitro by allosensitization

1 reference

https://pubmed.ncbi.nlm.nih.gov/3886826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES

1 reference

https://pubmed.ncbi.nlm.nih.gov/3886826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Restoration of allograft responsiveness in B rats by interleukin 2 and/or adherent cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3886826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3886826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/3886826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/3886826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 allows in vivo induction of anti-erythrocyte autoantibody production in nude mice associated with the injection of rat erythrocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/3886826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3886826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3886826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The fate of interleukin-2 after in vivo administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/3886826

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1084/JEM.161.5.1169

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36350050&oldid=1519258238"